NOK209.00
1.88% today
Oslo, May 21, 12:35 pm CET
ISIN
NO0010159684
Symbol
MEDI
Sector

Medistim Target price 2025 - Analyst rating & recommendation

Medistim Classifications & Recommendation:

Buy
33%
Hold
67%

Medistim Price Target

Target Price NOK211.00
Price NOK213.00
Deviation
Number of Estimates 2
2 Analysts have issued a price target Medistim 2026 . The average Medistim target price is NOK211.00. This is lower than the current stock price. The highest price target is
NOK250.00 17.37%
register free of charge
, the lowest is
NOK172.00 19.25%
register free of charge
.
A rating was issued by 3 analysts: 1 Analysts recommend Medistim to buy, 2 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Medistim stock has an average upside potential 2026 of . Most analysts recommend the Medistim stock at Hold.

Sales and Margin forecast 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Million NOK 562.60 619.69
6.89% 11.42%
EBITDA Margin 27.66% 26.81%
6.15% 0.03%
Net Margin 18.45% 18.14%
6.44% 2.82%

3 Analysts have issued a sales forecast Medistim 2025 . The average Medistim sales estimate is

NOK620m
Unlock
. This is
1.53% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
NOK655m 16.42%
Unlock
, the lowest is
NOK602m 7.00%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 NOK563m 6.89%
2025
NOK620m 11.42%
Unlock
2026
NOK662m 6.77%
Unlock
2027
NOK726m 9.65%
Unlock

3 Analysts have issued an Medistim EBITDA forecast 2025. The average Medistim EBITDA estimate is

NOK166m
Unlock
. This is
8.67% lower
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
NOK190m 22.12%
Unlock
, the lowest is
NOK154m 1.02%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 NOK156m 0.31%
2025
NOK166m 11.40%
Unlock
2026
NOK181m 9.12%
Unlock
2027
NOK219m 20.52%
Unlock

EBITDA Margin

2024 27.66% 6.15%
2025
26.81% 0.03%
Unlock
2026
27.40% 2.20%
Unlock
2027
30.12% 9.93%
Unlock

3 Medistim Analysts have issued a net profit forecast 2025. The average Medistim net profit estimate is

NOK112m
Unlock
. This is
8.49% lower
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
NOK128m 22.93%
Unlock
, the lowest is
NOK105m 0.88%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 NOK104m 0.00%
2025
NOK112m 8.30%
Unlock
2026
NOK123m 9.77%
Unlock
2027
NOK151m 22.11%
Unlock

Net Margin

2024 18.45% 6.44%
2025
18.14% 2.82%
Unlock
2026
18.65% 2.81%
Unlock
2027
20.77% 11.37%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share NOK 5.67 6.14
0.00% 8.29%
P/E 34.69
EV/Sales 6.06

3 Analysts have issued a Medistim forecast for earnings per share. The average Medistim EPS is

NOK6.14
Unlock
. This is
8.49% lower
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
NOK6.97 22.93%
Unlock
, the lowest is
NOK5.72 0.88%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 NOK5.67 0.00%
2025
NOK6.14 8.29%
Unlock
2026
NOK6.74 9.77%
Unlock
2027
NOK8.23 22.11%
Unlock

P/E ratio

Current 31.75 0.50%
2025
34.69 9.26%
Unlock
2026
31.60 8.91%
Unlock
2027
25.88 18.10%
Unlock

Based on analysts' sales estimates for 2025, the Medistim stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 6.15 4.41%
2025
6.06 1.53%
Unlock
2026
5.67 6.34%
Unlock
2027
5.17 8.80%
Unlock

P/S ratio

Current 6.39 3.50%
2025
6.30 1.51%
Unlock
2026
5.90 6.34%
Unlock
2027
5.38 8.80%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today